Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password
PMLiVE Top Pharma List

Zeria

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Zeria's Japan sales performance.

BMS presents positive four-year results for Opdivo combination in lung cancer

BMS presents positive four-year results for Opdivo combination in lung cancer

Opdivo is currently approved in more than 65 countries, including the US, EU, Japan and China for a range of indications such as melanoma, lung, kidney and gastric cancers.

AstraZeneca’s heart failure treatment recommended by NICE for expanded use

AstraZeneca’s heart failure treatment recommended by NICE for expanded use The therapy has also been approved in the US, EU, Great Britain, Japan and Turkey to extend the HF indication to include patients across the full spectrum of LVEF.

Bristol Myers Squibb’s Sotyktu approved by MHRA for plaque psoriasis

Bristol Myers Squibb’s Sotyktu approved by MHRA for plaque psoriasis Sotyktu is already approved in major markets, including in the US and Japan.

GSK’s RSV vaccine approved by FDA for older adults

GSK’s RSV vaccine approved by FDA for older adults The final decision from the European Commission is expected in the coming months, while regulatory reviews are ongoing in Japan and several other countries.

AstraZeneca’s heart failure treatment approved for expanded use in US

AstraZeneca’s heart failure treatment approved for expanded use in US Farxiga is already approved to treat patients with type 2 diabetes, HFrEF and chronic kidney disease in over 100 countries, including the US, EU, China and Japan. ... As well as this most recent US approval, Farixga has also been approved in the EU,

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Global Data

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Subscribe to our email news alerts

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...

Quick links